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OBJECTIVES To positively establish the diagnosis of myocardial stunning in patients with unstable angina
and persistent wall motion abnormalities after reperfusion by coronary angioplasty.
BACKGROUND Although myocardial stunning is thought to occur in several clinical conditions, definite proof
of its existence in humans is still lacking, owing to the difficulty of measuring myocardial
blood flow (MBF) in absolute terms.
METHODS We studied 14 patients with unstable angina due to proximal left anterior descending
coronary artery disease who presented persistent anterior wall motion abnormalities despite
revascularization of the culprit lesion by percutaneous coronary angioplasty (PTCA) and who did
not have clinical evidence of necrosis. Dynamic positron emission tomography (PET) with
[13N]-ammonia and [11C]-acetate was performed 48 h after PTCA to determine absolute MBF
and oxygen consumption (MVO2). Regional wall thickening and regional cardiac work were
determined using two-dimensional echocardiography. Improvement of segmental wall motion
abnormalities was followed for a median of 4 months (1.5 to 14 months).
RESULTS As judged from the changes in segmental wall motion score, regional dysfunction was
spontaneously reversible in 12/14 patients and improved from 2.2 6 0.3 to 1.2 6 0.3 at late
follow-up (p , 0.001). With PET, [13N]-ammonia MBF was similar among dysfunctional
and remote normally contracting segments (85 6 29 vs. 99 6 20 mlzmin21z100g21, p 5 not
significant [n.s.]), thus demonstrating a perfusion-contraction mismatch. Despite the reduced
contractile function, dysfunctional myocardium presented near normal levels of MVO2
(6.5 6 4.2 vs. 8.0 6 1.9 mlzmin21z100g21, p 5 n.s.). Consequently, the regional myocardial
efficiency (regional work divided by MVO2) of the dysfunctional myocardium was found to
be markedly decreased as compared with normally contracting myocardium (6 6 6% vs. 26 6
6%, p , 0.001).
CONCLUSIONS This study demonstrates that human dysfunctional myocardium capable of spontaneously
recovering contractile function after unstable angina endures a state of perfusion-contraction
mismatch. These data for the first time provide unequivocal direct evidence for the existence
of acute myocardial stunning in humans. (J Am Coll Cardiol 1999;34:1939–46) © 1999 by
the American College of Cardiology
Reversible postischemic dysfunction, or myocardial stun-
ning (1,2), is the contractile dysfunction that persists after
reperfusion despite the absence of irreversible myocardial
damage and despite restoration of normal or near-normal
coronary flow (3). Myocardial stunning is a well-defined
experimental entity that can be observed in several animal
species (4) following reperfusion after complete coronary
occlusions (1,5–7) or after prolonged low flow ischemia (8).
Although myocardial stunning is thought to occur in several
clinical conditions (9) such as during unstable angina
(10–14), after coronary spasm (15–17) or after exercise
induced ischemia (18–22), definite evidence of its existence
in humans is still lacking, mainly owing to the difficulty of
measuring myocardial blood flow (MBF) in absolute terms.
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We used positron-emission tomography (PET) and dy-
namic imaging using 13N-ammonia to assess MBF nonin-
vasively in an attempt to establish the diagnosis of myocar-
dial stunning positively in patients with unstable angina and
persistent wall motion abnormalities after reperfusion by
coronary angioplasty.
METHODS
Patient selection. The study comprised 14 patients (7 men
and 7 women, mean age 63 6 12 years, range 43 to 79 years)
admitted to the coronary care unit for unstable coronary
syndromes due to proximal left anterior descending coro-
nary artery (LAD) disease. The individual clinical charac-
teristics of this study population are summarized in Table 1.
Patients were considered eligible for inclusion in the study if
they presented with: 1) one-vessel disease with severe
proximal LAD stenosis or occlusion with successful revas-
cularization of the culprit lesion by balloon angioplasty or
stenting, 2) persistent contractile dysfunction of the anterior
wall after coronary revascularization, and 3) no signs of
myocardial necrosis defined as no Q-waves on the electro-
cardiogram (ECG) and no elevation of creatine phosphoki-
nase levels. The study protocol was approved by the Ethical
Committee of the University of Louvain Medical School
and all patients gave informed consent to the investigative
nature of this study.
Study protocol. Patients were enrolled in the study if
resting echocardiograms displayed persisting contractile
dysfunction in the anterior wall on the day after coronary
revascularization. Positron-emission tomography was ob-
tained as soon as possible after coronary angioplasty to
obtain measurements of resting MBF and oxygen consump-
tion in the dysfunctional area. Echocardiographic studies of
contractile function of the anterior wall were performed at
the time of the PET study and at regularly scheduled
control visits after angioplasty over a period of six months or
until complete normalization of anterior wall dysfunction.
Two-dimensional echocardiography. Two-dimensional
echocardiograms were analyzed in digitized cinequad loop
format on a computer workstation. Regional wall motion
was analyzed both qualitatively (regional wall motion) and
quantitatively (percent wall thickening) by the consensus of
two experienced observers (B.L.G. and J.L.V.O.). Regional
wall motion was interpreted in 16 myocardial segments (23)
and graded either as normal 1), hypokinetic 2) or akinetic
3). Intraobserver concordance for wall motion score was
84% (kappa 5 0.68) whereas interobserver concordance was
83% (kappa 5 0.62). A wall motion score for the segments
supplied by the LAD was calculated by summing up the
scores of the mid- and basal level of the septal, antero-septal
and anterior wall and of the septal, anterior and lateral part
of the apex. End-diastolic and end-systolic internal dimen-
sions of the left ventricle were measured on parasternal
Abbreviations and Acronyms
ECG 5 electrocardiogram
LAD 5 left anterior descending coronary artery
MBF 5 myocardial blood flow
MVO2 5 myocardial oxygen consumption
PET 5 positron-emission tomography
PTCA 5 percutaneous coronary angioplasty
Table 1. Characteristics of the Study Population
Patient
# Age/Gender
Clinical
Presentation
ECG After
Revascularization
% Stenosis
Culprit Lesion LVEF %
LAD-WMS
After
PTCA Follow-up
1 71/F UA 2B (RS) 2T V2–V6 90% 50% 2.4 1.4
2 44/M UA 3B 2T V2–V6, DI, VL 100% 52% 1.9 1.0
3 49/M UA 3B N1 90% 77% 1.8 1.0
4 42/M UA 2B 2T V2–V6, DI, VL 90% 66% 2.2 1.0
5 79/M UA 3B 2T V2–V5 100% 42% 2.6 1.3
6 54/M UA 3B 2T V2–V5 90% 57% 2.2 1.1
7 73/M UA 2B 2T V4–V6 100% 67% 1.8 1.1
8 63/M UA 3B 2T V2–V6, DI, VL 100% 66% 2.2 1.3
9 61/F UA 2B 2T V2–V6 80% 52% 2.3 1.4
10 75/F AMI 2T V1–V6 100% 78% 2.7 1.9
11 74/F AMI-UA 3C 2T V1–V6, DI 90% 47% 2.0 1.0
12 70/F UA 3B (RS) 2T V1–V6, DI 90% 58% 2.6 1.1
13 71/F UA 3B (RS) N1 80% 42% 2.6 n/a
14 52/M UA 3B 2T V2–V5 100% 67% 2.2 1.0
Mean 63 6 12, 7F UA 12, AMI 2 — 93 6 7% 59 6 12% 2.2 6 0.3 1.2 6 0.3*
AMI 5 acute myocardial infarction; ECG 5 electrocardiogram; 2T 5 negative T-waves, N1 5 Normal; LAD-WMS 5 wall motion score in the left anterior descending artery
dependent region; LVEF 5 left ventricular ejection fraction; RS 5 restenosis of a previously treated lesion; UA 5 unstable angina-Braunwald classification.
*p , 0.001, follow-up vs. baseline.
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M-mode images. Systolic wall thickening of the midante-
rior and mid-lateral segments was calculated from high
quality digitized two-dimensional echocardiographic frames
as the difference between systolic (R-wave of the ECG) and
diastolic (time of aortic valve closure) thickness and ex-
pressed in percent of the diastolic wall thickness. Meridional
wall stress and regional mechanical work (24) of both the
anterior (dysfunctional) and lateral (remote) wall were also
calculated by use of the following equations:
sm 5
1.33zLVPzLVD
4zWthz~1 1 Wth/LVD!
RW 5 2* smzd ln(1/Wth)
where LVD (cm): left ventricular dimension, LVP (mm
Hg): left ventricular pressure, RW (mJ/cm3): regional work,
Wth (cm): wall thickness, sm (g/cm
2): meridional wall
stress. The intraobserver reproducibility calculated as intra-
class correlation coefficient was 0.85, while interobserver
variability was 0.86. Contractile efficiency (%) was com-
puted as the ratio of regional work to regional myocardial
oxygen consumption (MVO2).
PET. Positron-emission tomography was performed using
ECAT III and ECAT EXACT HR tomographs (25).
Absolute MBF was quantified using 13N-ammonia and
MVO2 using
11C-acetate. One dynamic midventricular
transaxial study was analyzed per patient. Two large irreg-
ular volumes of interest were drawn onto the anterior
(dysfunctional) and lateral (remote) wall of the myocardium,
respectively. In each volume of interest, absolute regional
myocardial perfusion was quantified by use of a three-
compartment model (26), and regional oxidative metabo-
lism was estimated from the rapid exponential clearance rate
of the 11C-activity from the myocardium to derive kmono.
MVO2 was calculated based on the relationship between
MVO2 and kmono that had been determined in prior studies
(27).
Statistical analysis. Values are expressed as means 6 one
standard deviation. Comparisons between wall motion score
at baseline and after follow-up and of differences of param-
eters between the dysfunctional anterior and remote lateral
wall were made using the Student t test for paired samples.
All tests were two-tailed and a p value of less than 0.05 was
considered indicative of statistical significance.
RESULTS
Baseline clinical and angiographical characteristics. The
individual clinical and angiographical characteristics of the
study population are shown in Table 1. In 12 patients the
initial clinical presentation corresponded to unstable angina
of the Braunwald class 2B and 3B (28). The two remaining
patients presented with features typical of acute myocardial
infarction (ST elevation and chest pain nonresponsive to IV
nitrates and heparin) which completely resolved during
thrombolysis. In each case, no anterior Q-waves developed
and cardiac enzymes always remained within the normal
limits for our laboratory (,160 IU/ml). Coronary angiog-
raphy and successful revascularization of the LAD were
performed at a median of four days (range 1 to 23 days) after
the onset of the acute coronary syndrome. The proximal
LAD was occluded in six patients and showed .80%
stenosis in the remaining eight patients. Revascularization
was performed using balloon angioplasty in 13 patients and
using directional atherectomy in 1 patient. Three patients
underwent implantation of an endovascular stent. All pa-
tients presented complete akinesis of the anterior and apical
wall at contrast angiography. Mean ejection fraction at the
time of coronary angioplasty was 59 6 12%. All patients
were treated with IV nitrates, heparin and aspirin before
undergoing coronary angioplasty. Additional treatment
consisted of beta-adrenergic blocking agents in eight pa-
tients and calcium antagonists in four patients. The peak
creatine kinase enzyme level averaged 134 6 142 U/ml. The
ECG at the time of the PET study displayed ample and
negative T-waves in 12 patients. No patient had patholog-
ical Q-waves or ST elevation or depression at the time of
the PET study.
Contractile function at baseline and spontaneous recov-
ery over time. Tomographic and echocardiographic acqui-
sitions were performed 2 6 2 days (range 1 to 7 days) after
coronary revascularization (Fig. 1). At the time of the PET
study, all patients displayed severe dysfunction of the
LAD-dependent anterior wall with complete akinesis of the
mid- and apical-anterior segments. The average wall mo-
tion score for the LAD-dependent segments was 2.2 6 0.3.
Serial echocardiographic follow-up was obtained in 13 of
the 14 patients. The remaining patient was lost to follow-
up. The median time of follow-up was four months (range
1.5 to 14 months). The time course of recovery of LAD-
dependent wall-motion score, assessed by repeated echocar-
diographic studies is illustrated in Figure 2. Slow spontaneous
improvement of the contractile dysfunction (improvement
of wall motion score from 2.2 6 0.3 before percutaneous
coronary angioplasty [PTCA] to 1.2 6 0.3 after follow-up,
p , 0.001) occurred over time in all patients but with an
interindividual variability. Eight patients completely nor-
Figure 1. Graph illustrating the delay between first occurrence of
symptoms and coronary revascularization and the time points
when PET studies were performed and when functional follow-up
was completed. PET 5 positron-emission tomography.
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malized contractile function, presenting less than one hy-
pokinetic segments at late follow-up. In four patients,
hypokinesis persisted in more than one (all apical) segment.
Finally, the recovery of contractile function was incomplete
in one patient (Patient 10) who remained akinetic in the
anterior and anteroseptal wall. Repeated coronary angiog-
raphy and cardiac catheterization were obtained in 10
patients and also demonstrated complete normalization of
contractile function in all patients.
Absolute myocardial perfusion and its relationship to
wall thickening. Absolute myocardial perfusion and wall
thickening in the anterior dysfunctional and remote regions
are shown in Figures 3 and 4. At the time of the PET study,
wall thickening in the anterior wall was reduced to 9 6 8%
of the thickening of the remote lateral wall (p , 0.001, Fig.
3A). In contrast, absolute myocardial blood perfusion in the
dysfunctional anterior wall was well preserved at 87 6 27%
of the remote region and, on average, did not significantly
vary between the dysfunctional anterior and the remote
normally contracting segments (85 6 29 vs. 99 6 20
mlzmin21z100g21, p 5 NS, Fig. 3B). The values of blood
flow were within the 95% confidence limits (60 to 138
mlzmin21z100g21) of the remote region in all but two
patients. One of these two patients (Patient 10) displayed
incomplete recovery of wall motion at follow-up. Figure 4
illustrates the relationship between reduction of wall thick-
ening and reduction of myocardial perfusion observed in our
patients. This figure clearly demonstrates the discrepancy
between preserved perfusion and reduced wall thickening
that is characteristic of a contraction-perfusion mismatch.
Myocardial oxygen consumption and regional work. Fig-
ure 5 illustrates the average values of resting regional work
and oxygen consumption in both the anterior and remote
regions. The anterior wall performed only 13 6 11% of the
contractile work performed by the normally contractile
remote region (0.6 6 0.6 J/beat vs. 5.4 6 1.6 J/beat, p ,
0.001). In contrast, MVO2 did not significantly vary be-
tween the anterior and remote regions 6.5 6 4.2 vs. 8.0 6
1.9 mlzmin21z100g21, p 5 n.s.). Consequently, the regional
mechanical efficiency of the anterior wall was found to be
reduced as compared with the remote region (6 6 6% vs.
26 6 6%, p , 0.001, Fig. 6).
Figure 2. Plot illustrating the time course of spontaneous recovery
of contractile function of the stunned myocardium after coronary
angioplasty.
Figure 3. (A) Bar graph showing percentage of wall thickening in
the stunned anterior and remote normally contracting region. Wall
thickening was significantly reduced (p , 0.001) in the stunned
myocardium. (B) Bar graph showing resting MBF in the stunned
anterior and remote normally contracting region. There was no
significant reduction of MBF in the anterior as compared with the
remote myocardium. MBF 5 myocardial blood flow.
Figure 4. Relationship between absolute MBF and wall thicken-
ing in the anterior region (closed circles) with respect to the
remote lateral region (open circles). In the anterior region, wall
thickening was found to be reduced to 9% of the remote, whereas
blood flow was maintained at 87% of the remote region, thus
illustrating a perfusion-contraction mismatch. MBF 5 myocardial
blood flow.
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DISCUSSION
In this study we attempted to positively demonstrate the
presence of myocardial stunning in 14 patients with unsta-
ble coronary syndromes with proximal LAD disease and
persistent anterior wall dysfunction despite revascularization
of the culprit LAD lesion. Contractile function spontane-
ously recovered over time, confirming the absence of myo-
cardial necrosis in 12 out of 14 patients. Absolute myocar-
dial perfusion was measured using PET at the time of
dysfunction and was not found to be significantly reduced in
the dysfunctional region. Myocardial oxygen consumption
remained preserved, thus indicating a reduced contractile
efficiency of the dysfunctional tissue under resting condi-
tions.
Myocardial stunning in man. Myocardial stunning is an
experimentally observed (1,5) postischemic event that is
characterized by persisting contractile dysfunction of the
postischemic but reperfused myocardium with a spontane-
ous recovery over time (2). In the experimental setting,
stunning was demonstrated to be an oxygen radical medi-
ated reperfusion injury to the calcium channels and contrac-
tile proteins, resulting in intracellular calcium overload and
reduced excitation coupling of the contractile myofilaments
of the stunned myocyte (3). It is generally accepted among
clinical cardiologists that myocardial stunning is a phenom-
enon that occurs as frequently as ischemia itself in many
patients with various cardiac diseases. Stunning therefore
has been postulated to exist in a variety of situations (9,29)
such as in reperfused myocardial infarction (30–32), after
unstable angina (10–14) or in coronary spasm (15–17),
following recovery of exercise-induced ischemia (18–20,33)
or after cardiopulmonary bypass surgery. However, unlike
the situation in animals, full reperfusion is rarely achieved in
humans (34), and it is likely that other pathophysiological
situations such as myocellular necrosis, ongoing ischemia
and short-term hibernation may coexist within dysfunc-
tional human myocardium. Hence, the presence of myocar-
dial stunning in the clinical situation has most often been
inferred, and direct evidence for the ocurrence of myocardial
stunning in man is still lacking (9).
Positive diagnosis of the occurrence of myocardial stun-
ning in man. By definition, the positive diagnosis of
myocardial stunning requires documentation of the revers-
ibility of the dysfunction as well as the analysis of the
relationship between perfusion and contraction, demon-
strating a perfusion contraction mismatch (35) at the time
when reperfusion has been performed and dysfunction
persists (9). To provide such evidence, it is important to
carefully select patients in whom evidence of ongoing
ischemia or necrosis is definitely lacking. In this study, we
therefore chose to select patients with unstable angina but
without any signs of myocardial infarction, as demonstrated
by the absence of enzymatic elevation or electrocardio-
graphic Q-waves on the 12-lead ECG, who presented with
persisting wall motion abnormalities despite successful
PTCA of the culprit lesion of the proximal LAD and
complete akinesis of the anterior wall that persisted until the
PET studies were performed.
At the time of the study, the majority of the patients
presented with negative T-waves in the precordial chest
derivations of the 12-lead ECG. Previous work from de
Zwaan et al. (36) and Renkin et al. (12) has indicated that
when this particular ECG pattern occurs in the presence of
a severe proximal LAD stenosis, it is often associated with
resting segmental dysfunction that slowly recovers after
recanalization and may represent the electrophysiological
correlate of functional stunning. In this study, we also
demonstrated a slow and spontaneous recovery of contrac-
tile function that was gradual over time. Several authors had
previously demonstrated such complete recovery of contrac-
tile function in patients after attacks of unstable angina
(10–14) or myocardial infarction. The time course of
recovery of contractile function is still poorly known but was
shown to span between several hours (13) and two weeks
(37) after reflow. In our study, the recovery of contractile
function appeared to be slower and, in some patients, took
Figure 6. Bar graph showing contractile efficiency in the dysfunc-
tional anterior and remote lateral regions. Anterior contractile
efficiency was significantly (p , 0.001) lower than remote con-
tractile efficiency.
Figure 5. Bar graph showing contractile work (left) and MVO2
(right) of the dysfunctional anterior and remote lateral region.
Contractile work was significantly (p , 0.001) reduced in the
anterior with respect to the remote region, whereas MVO2 was
found to be well-preserved. MVO2 5 myocardial oxygen con-
sumption.
1943JACC Vol. 34, No. 7, 1999 Gerber et al.
December 1999:1939–46 Acute Myocardial Stunning in Humans
up to four months to occur. This slower recovery of function
was confirmed by reports of Renkin et al. (12) and de Feijter
et al. (38) and most likely resulted from more severe or more
pronounced previous ischemic attacks, as previously re-
ported in experimental animal studies (39,40). To positively
demonstrate a state of myocardial stunning beyond the
demonstration of spontaneous recovery of contractile func-
tion, we also had to demonstrate the presence of a
contraction-perfusion mismatch (35) at the time of dysfunc-
tion. Therefore quantitative measurements of absolute myo-
cardial perfusion were performed using PET and 13N-
ammonia. While contractile dysfunction persisted, we
found that perfusion was completely restored in the majority
of patients, thus illustrating the presence of a perfusion-
contraction mismatch. Previous studies addressing the issue
of myocardial perfusion in patients with reperfused myocar-
dium only concentrated on patients with reperfused infarc-
tion (41–43). As expected from the known admixture of
necrotic and normal tissue after infarction, all these studies
concur in demonstrating reduced perfusion in the dysfunc-
tional tissue. With regard to unstable angina or coronary
spasms, only a few case reports have been published (44,45),
none providing quantitative measurements of MBF at the
time of postischemic dysfunction. This study therefore
represents the first unequivocal demonstration that myocar-
dial stunning occurs in humans and, in particular, following
attacks of unstable angina.
Myocardial oxygen consumption and efficiency in
stunned myocardium. A second important question ad-
dressed in this study concerns resting oxidative metabolism
and mechanical efficiency in the dysfunctional stunned
myocardium. Under normal conditions, MVO2 has been
shown to be tightly correlated with the contractile work.
The relation between oxygen consumption and decreased
contractile function in the dysfunctional but stunned myo-
cardium is still a matter of debate (46). Experimental
observations in animal models of myocardial stunning have
indeed yielded some conflicting results. While some studies
reported unchanged (47,48) or even increased (49) MVO2
in stunned myocardium, others (50–52) reported reduced
oxygen consumption in the stunned myocardium. Some of
these discrepancies may be explained by the inherent diffi-
culty of directly measuring oxygen consumption in the heart
in vivo and thus by measurement errors or methodological
issues. Indeed, reductions of absolute oxygen consumption
were moderate—less than 25% of preischemic levels—and
therefore out of proportion with the depressed postischemic
regional work. These reductions seem to parallel the levels
of perfusion that may also be found to be slightly reduced
after reperfusion, as previously discussed. In this study,
resting oxygen consumption was found to be maintained in
the dysfunctional regions despite the reduced mechanical
work performed by the stunned myocardium. Thus, the
stunned human myocardium was found to have, as previ-
ously demonstrated in animal studies (48,52), a reduced
mechanical efficiency.
Study limitations. This study has some limitations that are
related to the use of PET for the measurements of perfusion
and oxygen consumption in dysfunctional myocardium.
Because part of the study was performed using a single slice
tomograph, dynamic data were acquired at a single tomo-
graphic level, corresponding to the midventricular level of
the heart. It is therefore assumed that the anterior wall at
this tomographic level was representative of the entire
territory of the LAD. Also, in an attempt to compensate for
the limited spatial resolution of the PET imaging device, all
individual time-activity curves were corrected for partial-
volume and spillover effects. Although such corrections are
a definite prerequisite for the measurement of MBF and
metabolism in absolute terms (26), particularly when deal-
ing with dysfunctional or thin myocardial walls, none of the
currently available methods are perfect. In this study, we
used a specially developed Monte-Carlo simulation to
generate individual correction factors for each myocardial
region of interest. This approach has been validated in dogs
over a wide range of thickness and thickening conditions
and allows accurate estimations of individual recovery coef-
ficients and spillover factors (26). Because quantitative
measurements of myocardial perfusion using PET encom-
pass transmural wall thickness, subendocardial blood flow
can not be assessed presently. Our observations of
perfusion-contraction mismatch can, therefore, not be ex-
tended to the subendocardial level. Finally, in our study one
patient (Patient 10) did not spontaneously recover function
during the time of observation. While the exact reason for
this is not entirely clear, this patient had presented with ST
elevations and received thrombolysis, yet without apparent
increase of creatine phosphokinase levels and without
pathologic Q-waves on the ECG. Despite the absence of
such objective signs of infarction, it is likely that the patient
had undergone an unrecognized but significant amount of
myocellular necrosis in the anterior wall, explaining the
limited recovery of function after reperfusion. It is also
possible that this patient had undergone microvascular
damage from the no-reflow phenomenon, which might
explain the reduced perfusion (41 ml/min/100g) observed at
the time of the study. This latter diagnosis may also apply to
another patient (Patient 8) who also presented with reduced
perfusion (38 ml/min/100g) and limited recovery of con-
tractile function. Thus, the diagnosis of myocardial stun-
ning, which clearly applies to all other 12 patients in our
study, is not applicable to these latter 2 patients, although
they fulfilled the inclusion criteria for our study.
Conclusions. This study demonstrated that human dys-
functional myocardium capable of spontaneously recovering
contractile function after an unstable coronary syndrome
endures a state of perfusion-contraction mismatch. This
study therefore provides unequivocal direct evidence for the
existence of myocardial stunning in humans.
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